Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07230444

Artificial Intelligence for the Intra-procedural Assessment of Uterine Artery Embolization

Sponsor: Emanuele Barabino

View on ClinicalTrials.gov

Summary

Uterine artery embolization is a minimally invasive treatment for symptomatic uterine fibroids, but intra-procedural assessment of embolization adequacy currently relies on subjective angiographic criteria. This study evaluates a proprietary angiographic analysis software (AQ-VERO) that extracts quantitative time-to-density perfusion metrics in real time. The study aims to (1) validate the accuracy and reproducibility of AQ-VERO during uterine artery mebolization, and (2) develop an AI-based decision support system using AQ-VERO-derived metrics to improve objective intra-procedural assessment of treatment endpoints.

Official title: Validation and Implementation With Artificial Intelligence of Software for the Intra-procedural Assessment of Uterine Artery EMBOlization

Key Details

Gender

FEMALE

Age Range

18 Years - 55 Years

Study Type

OBSERVATIONAL

Enrollment

250

Start Date

2025-12-01

Completion Date

2027-05-31

Last Updated

2025-11-19

Healthy Volunteers

No

Locations (1)

IRCCS OSpedale Policlinico San Martino

Genova, Genova, Italy